Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-14-011437
Filing Date
2014-07-03
Accepted
2014-07-03 13:29:19
Documents
1
Period of Report
2014-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3948
  Complete submission text file 0001179110-14-011437.txt   5166
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION RT. 141 & HENRY CLAY RD., BLDG. E336 WILMINGTON DE 19880
Business Address
FRIEDMAN PAUL A (Reporting) CIK: 0001236927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 14959905